Free Access
Med Sci (Paris)
Volume 29, Number 1, Janvier 2013
Page(s) 107 - 109
Section Dernières Heures
Published online 25 January 2013
  1. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF. Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2012 ; 2 : 276–286. [CrossRef] [PubMed] [Google Scholar]
  2. Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. J Clin Invest 2008 ; 118 : 3273–3275. [PubMed] [Google Scholar]
  3. Ison MG. Antivirals and resistance: influenza virus. Curr Opin Virol 2011 ; 1 : 563–573. [CrossRef] [PubMed] [Google Scholar]
  4. Ferraris O, Lina B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol 2008 ; 41 : 13–19. [CrossRef] [PubMed] [Google Scholar]
  5. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006 ; 12 : 1203–1207. [CrossRef] [PubMed] [Google Scholar]
  6. Riteau B, de Vaureix C, Lefevre F. Trypsin increases pseudorabies virus production through activation of the ERK signalling pathway. J Gen Virol 2006 ; 87 : 1109–1112. [CrossRef] [PubMed] [Google Scholar]
  7. Khoufache K, LeBouder F, Morello E, et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 2009 ; 182 : 7795–7802. [CrossRef] [PubMed] [Google Scholar]
  8. Coughlin SR, Camerer E. PARticipation in inflammation. J Clin Invest 2003 ; 111 : 25–27. [PubMed] [Google Scholar]
  9. Khoufache K, Berri F, Nacken W, et al. PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 2012 ; 3 décembre. doi: pii: 61667. 10.1172. [Google Scholar]
  10. Dreyfus C. Vers un vaccin universel contre la grippe ? Med Sci (Paris) 2013 ; 29 : 22–25. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.